C&P Exam Prep Guide for Benign skin neoplasms (DC 7819)

Read the C&P exam preparation guideWhat happens at the exam, what 38 CFR Part 4 requires the examiner to record, and what to bring.
Build your prep packet for this conditionOrganize the codes, your symptoms, records, and a body-map into one printable sheet. Private to your device.
Diagnostic code: 7819Condition: Benign skin neoplasmsRegulation: 38 CFR § 4.118DBQ: DERM Skin Diseases

YOUR EXAM BLUEPRINT

Benign skin neoplasms

A skin exam is a visual exam. The examiner looks at the affected areas, estimates how much of your body is involved, and notes what treatment you need, then rates under 38 CFR 4.118.

DC 7819

DBQ used for this condition

What the examination is likely to focus on

History and interviewWhen the condition started and how often it flares. Itching, pain, scaling, blisters, or oozing. Treatments used, especially how many weeks per year you need pills or injections that affect the immune system (systemic therapy) versus creams. Triggers and effect on daily life and work.
Physical examinationLooking at the affected skin and where it is on the body. Estimating the percentage of your total body affected, and the percentage of exposed areas (face, hands, neck). Noting the type of treatment you require. Photographing the affected skin.
Diagnostic testingUsually only to confirm the diagnosis. Skin biopsy, Skin scraping (KOH test).
Functional assessmentThe percentage of total body and of exposed area affected, and how many weeks per year you need systemic therapy, which set the rating. Effect on daily life and work. Findings map to the General Rating Formula for the skin in 38 CFR 4.118 (dermatitis or eczema DC 7806; dermatophytosis DC 7813; psoriasis DC 7816).

Functional-impact topics to describe

  • The percentage of total body and of exposed area affected, and how many weeks per year you need systemic therapy, which set the rating.
  • Effect on daily life and work.
  • Findings map to the General Rating Formula for the skin in 38 CFR 4.118 (dermatitis or eczema DC 7806; dermatophytosis DC 7813; psoriasis DC 7816).
This blueprint is preparation guidance, not a prediction of the examination or claim outcome.RateMyVSO.net

Which form the examiner uses

For benign skin neoplasms (DC 7819), the C&P examiner completes the following Disability Benefits Questionnaire (DBQ):

DBQs are Department of Veterans Affairs Form 21-0960 series documents. Public DBQs are hosted on benefits.va.gov. A handful are examiner-only and are not posted publicly.

The DBQ topics for this condition

These are the parts of the DBQ form that apply to benign skin neoplasms (DC 7819). Sections the form uses for other conditions are left out. Topics marked Only if this applies depend on your own history, such as surgery, a device, or a complication; open one if it applies to you. Section and question numbers are the ones printed on the VA form.

Skin Diseases

Open the full VA form (PDF, reference copy) Updated on: 2024-07-15

Section I Diagnosis Form page 2

  1. 1A. DOES THE VETERAN HAVE A CURRENT SKIN CONDITION?
    Options printed on the form (35)
    • For Burn Conditions, the SCARS/DISFIGUREMENT DISABILITY BENEFITS QUESTIONNAIRE must be completed.
    • IF YES, PROVIDE ONLY DIAGNOSES THAT PERTAIN TO SKIN CONDITIONS. INDICATE THE CATEGORY OF SKIN CONDITION, AND THEN PROVIDE
    • SPECIFIC DIAGNOSIS IN THAT CATEGORY (check all that apply):
    • Dermatitis or eczema
    • Diagnosis:
    • Tumors and neoplasms of the skin, including malignant melanoma
    • Diagnosis:
    • Dermatophytosis (ringworm: of body, tinea corporis; of head, tinea capitis; of feet, tinea pedis; of beard area, tinea barbae; of nails, tinea unguium (onychomycosis); of inguinal area (jock itch), tinea cruris; tinea versicolor)
    • Diagnosis:
    • Acne
    • Psoriasis
    • Infectious skin conditions not listed elsewhere (including bacterial, fungal, viral, treponemal and parasitic skin conditions)
    • Diagnosis:
    • Chronic Urticaria
    • Alopecia
    • Diagnosis:
    • Keratinization skin disorders (including icthyoses, Darier's disease, and palmoplantar keratoderma)
    • Diagnosis:
    • Erythroderma (exfoliative dermatitis)
    • Papulosquamous skin disorders not listed elsewhere (including lichen planus, large or small plaque parapsoriasis, pityriasis lichenoides et varioliformis acuta (PLEVA), lymphomatoid papulosus, mycosis fungoides and pityriasis rubra pilaris (PRP))
    • Diagnosis:
    • Hyperhidrosis
    • Vitiligo
    • Bullous disorders (including pemphigus vulgaris, pemphigus foliaceous, bullous pemphigoid, dermatitis herpetiformis, epidermolysis bullosa acquisita, benign chronic familial pemphigus (Hailey-Hailey), and porphyria cutanea tarda)
    • Diagnosis:
    • Cutaneous manifestations of collagen-vascular diseases not listed elsewhere (including scleroderma, calcinosis cutis, and dermatomyositis)
    • Diagnosis:
    • Chloracne
    • Discoid lupus or subacute cutaneous lupus erythematosus
    • Erythema multiforme (toxic epidermal necrolysis)
    • Primary cutaneous vasculitis
    • Other skin condition
    • Other diagnosis #1:
    • Other diagnosis #2:
    • Other diagnosis #3:

Section II Medical History Form page 3

  1. 2A. DESCRIBE THE HISTORY (including onset and course) OF THE VETERAN'S CURRENT SKIN CONDITIONS (brief summary):
  2. 2B. RESOLVED SKIN CONDITIONS - DID THE VETERAN PREVIOUSLY HAVE A SKIN CONDITION THAT IS NOW COMPLETELY RESOLVED AND NO LONGER REQUIRES TREATMENT OF ANY TYPE? (brief summary):
  3. 2C. COMMENTS, IF ANY:

Section III Treatment Form page 3

  1. 3A. HAS THE VETERAN BEEN TREATED WITH MEDICATION IN THE PAST 12 MONTHS FOR ANY SKIN CONDITION?
    Options printed on the form (73)
    • IF YES, CHECK ALL THAT APPLY:
    • Corticosteroids or other immunosuppressive medications (Specify condition medication used for): (Specify the route of administration): (Total duration of medication use in past 12 months):
      (If checked, list medication(s):
    • Oral
    • Suppository
    • Injection
    • Topical
    • Intranasal
    • Other:
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Antihistamines (Specify condition medication used for): (Specify the route of administration): (Total duration of medication use in past 12 months):
      (If checked, list medication(s):
    • Oral
    • Suppository
    • Injection
    • Topical
    • Intranasal
    • Other:
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Retinoids (Specify condition medication used for): (Specify the route of administration): (Total duration of medication use in past 12 months):
      (If checked, list medication(s):
    • Oral
    • Suppository
    • Injection
    • Topical
    • Intranasal
    • Other:
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Sympathomimetics (Specify condition medication used for): (Specify the route of administration): (Total duration of medication use in past 12 months):
      (If checked, list medication(s):
    • Oral
    • Suppository
    • Injection
    • Topical
    • Intranasal
    • Other:
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Biologics (Specify condition medication used for): (Specify the route of administration): (Total duration of medication use in past 12 months):
      (If checked, list medication(s):
    • Oral
    • Suppository
    • Injection
    • Topical
    • Intranasal
    • Other:
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Other medication
      (If checked, list medication(s):
    • (Specify condition medication used for): (Specify the route of administration): (Total duration of medication use in past 12 months):
    • Oral
    • Suppository
    • Injection
    • Topical
    • Intranasal
    • Other:
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Other medication (Specify condition medication used for): (Specify the route of administration): (Total duration of medication use in past 12 months):
      (If checked, list medication(s):
    • Oral
    • Suppository
    • Injection
    • Topical
    • Intranasal
    • Other:
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • NOTE: If a medication is used for more than one condition, provide names of all conditions, name of medication used for each condition, and frequency of use for each condition:
  2. 3B. HAS THE VETERAN HAD ANY TREATMENTS OR PROCEDURES OTHER THAN SYSTEMIC OR TOPICAL MEDICATIONS IN THE PAST 12 MONTHS FOR ANY SKIN CONDITION?
    Options printed on the form (26)
    • IF YES, CHECK ALL THAT APPLY:
    • Phototherapy such as ultraviolet-B light (UVB) treatment (Specify condition treated): (Total duration of medication use in past 12 months):
      (If checked, date of most recent treatment):
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Photochemotherapy (to include PUVA (psoralen with long wave ultraviolet A light)) treatment (Specify condition treated):
      (If checked, date of most recent treatment):
    • (Total duration of medication use in past 12 months):
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Electron beam therapy (Specify condition treated): (Total duration of medication use in past 12 months):
      (If checked, date of most recent treatment):
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Intensive light therapy (Specify condition treated): (Total duration of medication use in past 12 months):
      (If checked, date of most recent treatment):
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Other treatment (Specify treatment): (Specify condition treated): (Total duration of medication use in past 12 months):
      (If checked, date of most recent treatment):
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant
    • Other treatment (Specify treatment): (Specify condition treated): (Total duration of medication use in past 12 months):
      (If checked, date of most recent treatment):
    • <6 weeks
    • 6 weeks or more, but not constant
    • Constant/near-constant

Section IV Physical Exam Form page 6

  1. 4A. INDICATE THE VETERAN'S VISIBLE CHARACTERISTIC LESIONS DUE TO THE SKIN CONDITION(S); INDICATE THE APPROXIMATE TOTAL BODY AREA AND APPROXIMATE TOTAL EXPOSED BODY AREA (face, neck and hands) AFFECTED ON CURRENT EXAMINATION (check all that apply):
    • Other
    • Indicate diagnosis:
    • Total body area
    • None
    • <5%
    • 5% to <20%
    • 20% to 40%
    • >40%
    • EXPOSED area
    • None
    • <5%
    • 5% to <20%
    • 20% to 40%
    • >40%
    • Other
    • Indicate diagnosis:
    • Total body area
    • None
    • <5%
    • 5% to <20%
    • 20% to 40%
    • >40%
    • EXPOSED area
    • None
    • <5%
    • 5% to <20%
    • 20% to 40%
    • >40%
    • Other
    • Indicate diagnosis:
    • Total body area
    • None
    • <5%
    • 5% to <20%
    • 20% to 40%
    • >40%
    • EXPOSED area
    • None
    • <5%
    • 5% to <20%
    • 20% to 40%
    • >40%
  2. 4B. FOR EACH SKIN CONDITION CHECKED IN ITEM 4A, GIVE SPECIFIC DIAGNOSIS AND DESCRIBE APPEARANCE AND LOCATION:

Section VI Tumors and Neoplasms Form page 9

  1. 6A. Does the Veteran currently have, or has had, a benign or malignant neoplasm or metastases related to any condition in the diagnosis section?
    • If yes, complete the following section.
  2. 6B. Is the neoplasm:
    • Benign
    • Malignant (if malignant complete the following):
    • Active
    • In remission
    • Primary
    • Secondary (metastatic) (if secondary, indicate the primary site, if known):
  3. 6C. Has the Veteran completed treatment or is the Veteran currently undergoing treatment for a benign or malignant neoplasm or metastases?
    Options printed on the form (15)
    • No; watchful waiting
    • If yes, indicate type of treatment the Veteran is currently undergoing or has completed (check all that apply):
    • Treatment completed
    • Surgery
      If checked, describe:
    • Date(s) of surgery:
    • Radiation therapy
    • Date of most recent treatment:
    • Date of completion of treatment or anticipated date of completion:
    • Antineoplastic chemotherapy
    • Date of most recent treatment:
    • Date of completion of treatment or anticipated date of completion:
    • Other therapeutic procedure
      If checked, describe procedure:
    • Date of most recent procedure:
    • Other therapeutic treatment
      If checked, describe treatment:
    • Date of completion of treatment or anticipated date of completion:
  4. 6D. Does the Veteran currently have any residuals or complications due to the neoplasm (including metastases) or its treatment, other than those already documented in the report above?
    • If yes, list residuals or complications (brief summary), and also complete the appropriate questionnaire:
  5. 6E. If there are additional benign or malignant neoplasms or metastases related to any of the diagnoses in the diagnosis section, describe using the above format:

Section VII Scarring and Disfigurement Form page 10

  1. 7A. DO ANY OF THE VETERAN'S SKIN CONDITIONS CAUSE SCARRING (REGARDLESS OF LOCATION), OR DISFIGUREMENT OF THE HEAD, FACE OR NECK?
    • (If "Yes," complete the Scars/Disfigurement DBQ).

Section VIII Other Pertinent Physical Findings, Complications, Conditions, Signs and/or Symptoms Form page 11

Only if this applies: Related additional findings, complications or scars are present.
  1. 8A. DOES THE VETERAN HAVE ANY OTHER PERTINENT PHYSICAL FINDINGS, COMPLICATIONS, CONDITIONS, SIGNS AND/OR SYMPTOMS RELATED TO ANY CONDITIONS LISTED IN THE DIAGNOSIS SECTION ABOVE?
    • (If "Yes," describe and complete the appropriate DBQ):
  2. 8B. COMMENTS, IF ANY:

Section IX Functional Impact Form page 11

  1. 9A. DO ANY OF THE VETERAN'S SKIN CONDITIONS IMPACT HIS OR HER ABILITY TO WORK?
    • (If "Yes," describe impact of each of the Veteran's skin conditions, providing one or more examples):

Section X Remarks Form page 12

Only if this applies: Additional explanation or examination limitations need to be recorded.
  1. 10A. REMARKS (If any):

2 other sections of this form cover other conditions, the examiner's signature, or answers you gave above, and are not part of this prep view. The examiner still works from the whole form.

This is a preparation view built from the current public VA forms. It is not an official VA crosswalk, it does not decide which exam VA orders, and it does not tell the examiner to skip anything. Measurements, diagnoses and opinions on the form are the examiner's to record.

What to expect at your C&P exam

A skin exam is a visual exam. The examiner looks at the affected areas, estimates how much of your body is involved, and notes what treatment you need, then rates under 38 CFR 4.118.

1Initial interview (history)

  • When the condition started and how often it flares.
  • Itching, pain, scaling, blisters, or oozing.
  • Treatments used, especially how many weeks per year you need pills or injections that affect the immune system (systemic therapy) versus creams.
  • Triggers and effect on daily life and work.

2Physical examination

  • Looking at the affected skin and where it is on the body.
  • Estimating the percentage of your total body affected, and the percentage of exposed areas (face, hands, neck).
  • Noting the type of treatment you require.
  • Photographing the affected skin.

3Diagnostic tests the examiner may rely on

Usually only to confirm the diagnosis.

Skin biopsy what's this?
A small sample examined under a microscope when the diagnosis is unclear.
Skin scraping (KOH test)
Checks for a fungus in conditions like ringworm.

4Functional assessment

  • The percentage of total body and of exposed area affected, and how many weeks per year you need systemic therapy, which set the rating.
  • Effect on daily life and work.
  • Findings map to the General Rating Formula for the skin in 38 CFR 4.118 (dermatitis or eczema DC 7806; dermatophytosis DC 7813; psoriasis DC 7816).

Test explainers open MedlinePlus (NIH National Library of Medicine), or Wikipedia where MedlinePlus has no matching page. This describes what happens and what is measured, not how to influence a result.

Rating Levels for DC 7819

The following tiers are reproduced from 38 CFR Part 4, the VA Schedule for Rating Disabilities. Toggle between the official VA criteria and a Plain English explanation.

Plain-English summaries are AI-generated to explain the official criteria. The official 38 CFR language is the binding legal standard. When in doubt, ask a VSO.

Evidence cited in published BVA decisions for DC 7819

Each row counts the issues for this diagnostic code that the Board granted or denied and whose decision text discussed that type of evidence. An issue is one condition the Board ruled on, and one decision can contain several. Remanded issues are not included. This is a count from the public record, not a prediction or a recommendation for any claim.

  • Service treatment records: discussed in 1,732 granted or denied BVA issues (439 granted; 1,293 denied)
  • Buddy / lay statements: discussed in 1,145 granted or denied BVA issues (301 granted; 844 denied)
  • Medical literature: discussed in 110 granted or denied BVA issues (24 granted; 86 denied)

What the Board discussed in granted decisions for DC 7819

The themes below were extracted by clustering 478 grant-factor sentences from published Board of Veterans Appeals decisions for this diagnostic code. Frequencies indicate how often each theme appeared in the sample. This is a factual aggregate of the public record, not advice or strategy for any specific claim.

  1. 28% Benefit of the doubt doctrine cited as legal standard
    The Board or examiner cited the statutory benefit of the doubt doctrine, noting that when evidence is in approximate balance or equipoise the claimant prevails, as a general legal principle applied to the decision.
    134 of 478 sample sentences
  2. 15% Benefit of the doubt applied to grant or increase rating
    The Board affirmatively resolved the benefit of the doubt in the Veteran's favor to grant service connection, assign a compensable rating, or award a higher evaluation under a specific diagnostic code.
    74 of 478 sample sentences
  3. 15% Preponderance of evidence against claim, benefit of doubt inapplicable
    The Board found the preponderance of evidence weighed against the claim or a higher rating, rendering the benefit of the doubt doctrine inapplicable and requiring denial.
    71 of 478 sample sentences
  4. 12% Examiner nexus opinion cited as at least as likely as not
    A VA or private examiner opined that the Veteran's current disability was at least as likely as not incurred in, caused by, or aggravated during military service.
    55 of 478 sample sentences
  5. 9% Evidence found in equipoise supporting grant of claim
    The Board determined that the lay and medical evidence was at least in relative equipoise on a material issue, supporting a grant of service connection or an increased rating.
    43 of 478 sample sentences
  6. 7% Skin or scar disability specifically found service-connected or ratable
    The Board found that the evidence supported service connection or a compensable rating for a specific skin condition, scar, neoplasm, callus, or related benign growth under a skin diagnostic code.
    32 of 478 sample sentences
  7. 6% Preponderance of evidence standard and adjudication framework noted
    The Board articulated the overarching adjudication standard — that VA must determine whether evidence supports the claim, is in equipoise, or preponderates against it — as a framework for the decision.
    31 of 478 sample sentences
  8. 4% Examiner opinion requested on nexus or etiology
    The Board directed that a VA examiner be asked to opine whether a current disability is at least as likely as not related to service or a service-connected condition.
    18 of 478 sample sentences
  9. 3% Examiner nexus opinion cited as negative or not at least as likely
    A VA examiner opined that a disability was not at least as likely as not related to service, caused by a service-connected condition, or aggravated during service.
    12 of 478 sample sentences
  10. 2% Weight of evidence found to support claim on preponderance
    The Board concluded that the preponderance of the evidence affirmatively supported the claim, warranting a grant of service connection or a specific disability rating without needing to invoke the benefit of the doubt.
    8 of 478 sample sentences

When the Board found the exam inadequate (DC 7819)

In 924 published Board of Veterans' Appeals decisions involving this condition, the Board found a C&P examination or medical opinion inadequate. Where the defect could be read from the decision, it was most often one of the following (counts are a floor from the decisions on file, not a total):

  1. 234 Failed to address a contention or part of the condition
  2. 188 Conclusion given without a supporting rationale
  3. 133 Veteran's lay statements not considered
  4. 63 Claims file or records not reviewed
  5. 45 Opinion relied on the absence of records instead of the evidence
  6. 23 Flare-ups or functional loss not addressed
  7. 23 Examiner said an opinion would require speculation
  8. 13 Exam too old to reflect current severity
  9. 7 Wrong legal standard or question applied

An inadequate exam is usually sent back for a new one rather than decided against the veteran. This is a factual report of published decisions, not advice about any exam or claim; whether an exam is adequate is decided case by case.

Disclaimer: This page reproduces public Department of Veterans Affairs forms (DBQs) and verbatim text from 38 CFR Part 4 (the VA Schedule for Rating Disabilities). It is informational only and is not legal or medical advice. For guidance on a specific claim, contact a VA-accredited representative.